Embracing AI in Clinical Trials: An Oncology CRO’s Insight
In our previous article, we outlined how AI may improve different areas of the oncology drug development process. The integration… [read more]
Read articleYou need the right data, as early as possible, to optimize the results of your oncology drug development efforts. As a specialty oncology CRO, Medelis has the breadth of capabilities, depth of expertise, focus and agility to deliver accurate results – quickly.
For our clients, this means more than completing your trial on time and on budget; it also provides the decision support to determine your next clinical move.
In our previous article, we outlined how AI may improve different areas of the oncology drug development process. The integration… [read more]
Read articleThe release of GPT 3.5 and the improvement of large language models (LLMs) has captured the imagination of many around… [read more]
Read articleThe U.S. Food and Drug Administration (FDA) recently issued new guidance on the diversity of clinical trials, encouraging sponsors to… [read more]
Read article